Inactivity of terbinafine in a rat model of pulmonary aspergillosis Journal Article


Authors: Schmitt, H. J.; Andrade, J.; Edwards, F.; Niki, Y.; Bernard, E.; Armstrong, D.
Article Title: Inactivity of terbinafine in a rat model of pulmonary aspergillosis
Abstract: In a model of bronchopulmonary aspergillosis terbinafine did not improve survival of experimental animals in doses up to 80 mg/kg/day despite adequate lung concentrations. Pretreatment and aerosolization of the compound were also ineffective. Terbinafine was markedly less active in vitro when serum was used instead of Yeast-Nitrogen-Glucose-broth. It is concluded that a lack of bioavailability in the presence of serum may explain the lack of activity of terbinafine in experimental aspergillosis. © 1990 Friedr. Vieweg & Sohn Verlagsgesellschaft mbH.
Keywords: survival; controlled study; drug efficacy; nonhuman; animal; animal tissue; bioassay; rat; lung; drug tissue level; rats; disease models, animal; antifungal agents; aspergillus fumigatus; aspergillosis; lung aspergillosis; bioavailability; biological availability; experimental infection; antimicrobial activity; minimum inhibitory concentration; naphthalenes; intraperitoneal drug administration; amphotericin b; rats, inbred strains; aerosols; lung diseases, fungal; lung weight; aspergillus flavus; aspergillus niger; male; priority journal; article; inhalational drug administration; terbinafine
Journal Title: European Journal of Clinical Microbiology and Infectious Diseases
Volume: 9
Issue: 11
ISSN: 0934-9723
Publisher: Springer  
Date Published: 1990-11-01
Start Page: 832
End Page: 835
Language: English
DOI: 10.1007/bf01967386
PUBMED: 2128278
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Donald Armstrong
    240 Armstrong
  2. Edward M Bernard
    58 Bernard
  3. Fitzroy F Edwards
    23 Edwards